Zasocitinib Impurity 3 | CAS 3116745-59-3 - Request Quote
Zasocitinib Impurity 3
| SZ CAT No: | SZ-Z033004 |
| CAS No | 3116745-59-3 |
| Mol.F. | C22H25NO4 |
| Mol.Wt. | 367.4 |
| Inv. Status | Synthesis on demand |
Chemical Name :
Shipping Temperature :
HSN Code :
Country of Origin :
Smiles :
Usage Note:
Zasocitinib Impurity 3 is chemically 4-((1R,2R)-2-(dibenzylamino)cyclobutoxy)-4-oxobutanoic acid. Zasocitinib Impurity 3 is supplied with detailed characterization data compliant with regulatory guideline. Zasocitinib Impurity 3 can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Zasocitinib.
The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.
Applications & Regulatory Use Cases
Buy 3116745-59-3
Purchase 3116745-59-3
Order 3116745-59-3
Enquire 3116745-59-3
price of 3116745-59-3
3116745-59-3 Supplier
3116745-59-3 Manufacturer
3116745-59-3 Exporter
buy high quality Zasocitinib Impurity 3
Purchase Zasocitinib Impurity 3
Zasocitinib Impurity 3 suppliers
Zasocitinib Impurity 3 manufacturers
Zasocitinib Impurity 3 price
Order Zasocitinib Impurity 3
Enquire Zasocitinib Impurity 3
Zasocitinib Impurity 3 cost
Zasocitinib Impurity 3 Supplier
Zasocitinib Impurity 3 Distributor
Zasocitinib Impurity 3 for Method Validation
Zasocitinib Reference Standard
Zasocitinib Impurity 3 for ANDA Filing
Zasocitinib Impurity 3 for Forced Degradation Studies
Zasocitinib Impurity 3 Identification Standards
Zasocitinib Impurity 3 for DMF Filing
Related Products
Disclaimer
SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.
SynZeal will update these details as per new developments or findings in product specifications without further notice.